tiprankstipranks
PremiumClass ActionLost Money on Kyverna Therapeutics, Inc.(KYTX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP
4M ago
JPMorgan healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
4M ago
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
Premium
The Fly
Kyverna shares remain ‘significantly under-valued,’ says JPMorgan
4M ago
Kyverna Therapeutics anounces patient data on KYV-101
PremiumThe FlyKyverna Therapeutics anounces patient data on KYV-101
4M ago
Premium
Company Announcements
Kyverna Therapeutics Advances in Cell Therapy Leadership
5M ago
Kyverna Therapeutics reports Q3 EPS (80c), consensus (79c)
Premium
The Fly
Kyverna Therapeutics reports Q3 EPS (80c), consensus (79c)
5M ago
Kyverna announces presentation on KYV-101 at ECTRIMS
PremiumThe FlyKyverna announces presentation on KYV-101 at ECTRIMS
6M ago
Premium
Company Announcements
Kyverna Therapeutics Announces Executive Leadership Changes
6M ago
Kyverna Therapeutics names Warner Biddle as CEO, succeeding Peter Maag
Premium
The Fly
Kyverna Therapeutics names Warner Biddle as CEO, succeeding Peter Maag
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100